EN | RU
EN | RU

Help Support

Back

Gastroenterology

Filter By Diseases (0)

How much time do you have? in mins

All Content

65
Summaries

Evaluation of antimicrobial concentrations in gastric tissues for...

Optimizing the levels and distribution of antibacterial drugs in the gastric mucosa is crucial for achieving effective H. pylori elimination rate...

88
Medical News

Study reveals new findings for erosive esophagitis therapy

Potassium-competitive acid blockers are safe and effective, especially for 2-week short-term use, severe erosive esophagitis, and maintenance the...

35
Medical News

Fexuprazan offers superior gastritis relief in two weeks compared...

Fexuprazan outperforms Rebamipide in treating acute gastritis over two weeks and matches its effectiveness over four weeks, thereby offering quic...

42
Summaries

Long-term mortality in alcohol-related liver disease: Insights fr...

Patients with alcohol-related liver disease face a high risk of death due to liver disease long after diagnosis, with specific cancers like hepat...

71
Medical News

Study: Tirzepatide for fight against steatohepatitis and liver fi...

Tirzepatide notably improves liver condition and fibrosis outcomes, and warrants consideration for inclusion in treatment strategies.

75
Summaries

Do lifestyle changes lower the risk of mortality in NAFLD patient...

Adopting a healthy lifestyle drastically lowers all-cause and cardiovascular mortality risks in patients with nonalcoholic fatty liver disease, w...

60
Medical News

Dialysis fatigue and recovery time remain unaffected by PPIs

Proton pump inhibitors do not affect recovery time or fatigue in hemodialysis patients, confirming their safety in managing these symptoms.

65
Summaries

Xiangsha Liujunzi effective and safe for functional dyspepsia

Gastrointestinal health can be improved with Xiangsha Liujunzi decoction which enhances motility, protects the mucosa, and moderates inflammation...

58
Medical News

Serum Angpt-2: Key diagnostic biomarker for diabetic kidney disea...

Serum Angiopoietin-2 shows immense potential as an early marker for diabetic kidney disease in children, supporting its future therapeutic prospe...

195
Regulatory News

Takeda and Dr. Reddy’s join forces to launch Vonoprazan in India

Dr. Reddy’s has partnered with Takeda to launch Vonoprazan (VONO™), a novel acid blocker enhancing its GI treatment offerings in Indi...

156
Medical News

How diet affects GERD risk!

The risk of chronic acid reflux can be reduced with minor dietary adjustments, as fruits, fish, and grains provide protective benefits.

131
Medical News

Complex interplay between functional oesophagal disorders and psy...

In patients with PPI-unresponsive reflux, functional oesophagal disorders are not only prevalent but also strongly linked with worse psychologica...

Try: